La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Stepan Résultats passés
Passé contrôle des critères 1/6
Stepan's earnings have been declining at an average annual rate of -10.5%, while the Chemicals industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 7.1% per year. Stepan's return on equity is 2.9%, and it has net margins of 1.6%.
Informations clés
-10.5%
Taux de croissance des bénéfices
-10.3%
Taux de croissance du BPA
Chemicals Croissance de l'industrie | 12.9% |
Taux de croissance des recettes | 7.1% |
Rendement des fonds propres | 2.9% |
Marge nette | 1.6% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt
Aug 17Stepan Company Is Making Great Progress
Jul 28When Should You Buy Stepan Company (NYSE:SCL)?
Jul 24There Are Reasons To Feel Uneasy About Stepan's (NYSE:SCL) Returns On Capital
May 29Stepan Company's (NYSE:SCL) Price In Tune With Earnings
Apr 05Is There Now An Opportunity In Stepan Company (NYSE:SCL)?
Mar 22Is Stepan (NYSE:SCL) Using Too Much Debt?
Feb 18Stepan Company: It's Wise To Remain Cautious
Feb 17With Stepan Company (NYSE:SCL) It Looks Like You'll Get What You Pay For
Jan 04Capital Allocation Trends At Stepan (NYSE:SCL) Aren't Ideal
Dec 17Are Investors Undervaluing Stepan Company (NYSE:SCL) By 27%?
Dec 05Stepan Company: An Unfortunate Development Resulting In An Upside
Dec 03When Should You Buy Stepan Company (NYSE:SCL)?
Oct 16Stepan Company: Don't Try To Catch The Falling Knife, Still Potentially Overvalued
Sep 17Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet
Aug 31Stepan's Shares Are Reaching Even More Appealing Prices
Aug 28Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?
Jul 18Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital
Jul 06Stepan Company: A Downward Revision Is Warranted
Jun 09Is Stepan (NYSE:SCL) Using Too Much Debt?
May 23At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?
May 01Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth
Mar 25Returns On Capital At Stepan (NYSE:SCL) Have Stalled
Mar 08Stepan Q4 2022 Earnings Preview
Feb 15Here's Why Stepan (NYSE:SCL) Can Manage Its Debt Responsibly
Feb 02Stepan Company (NYSE:SCL) Shares Could Be 30% Below Their Intrinsic Value Estimate
Jan 05Stepan Company: Expect Outperformance To Continue
Jan 03Stepan (NYSE:SCL) Has Some Way To Go To Become A Multi-Bagger
Dec 03Stepan (NYSE:SCL) Is Paying Out A Larger Dividend Than Last Year
Nov 17Stepan Company: Consistent Dividend Growth In Times Of Uncertainty
Oct 13Stepan Company's (NYSE:SCL) Intrinsic Value Is Potentially 90% Above Its Share Price
Sep 20Ventilation des recettes et des dépenses
Comment Stepan gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 2,202 | 35 | 147 | 58 |
31 Mar 24 | 2,226 | 38 | 144 | 58 |
31 Dec 23 | 2,326 | 40 | 146 | 59 |
30 Sep 23 | 2,421 | 52 | 142 | 60 |
30 Jun 23 | 2,578 | 79 | 157 | 63 |
31 Mar 23 | 2,749 | 118 | 159 | 65 |
31 Dec 22 | 2,773 | 147 | 151 | 67 |
30 Sep 22 | 2,756 | 153 | 155 | 67 |
30 Jun 22 | 2,640 | 151 | 144 | 66 |
31 Mar 22 | 2,484 | 142 | 148 | 64 |
31 Dec 21 | 2,346 | 138 | 159 | 63 |
30 Sep 21 | 2,231 | 151 | 163 | 62 |
30 Jun 21 | 2,092 | 147 | 168 | 61 |
31 Mar 21 | 1,958 | 140 | 168 | 59 |
31 Dec 20 | 1,870 | 127 | 154 | 58 |
30 Sep 20 | 1,820 | 118 | 146 | 56 |
30 Jun 20 | 1,807 | 111 | 142 | 56 |
31 Mar 20 | 1,820 | 106 | 139 | 55 |
31 Dec 19 | 1,859 | 103 | 155 | 55 |
30 Sep 19 | 1,880 | 105 | 141 | 53 |
30 Jun 19 | 1,937 | 101 | 146 | 54 |
31 Mar 19 | 1,984 | 104 | 139 | 54 |
31 Dec 18 | 1,994 | 111 | 134 | 54 |
30 Sep 18 | 2,001 | 97 | 143 | 55 |
30 Jun 18 | 1,981 | 97 | 134 | 53 |
31 Mar 18 | 1,956 | 92 | 140 | 54 |
31 Dec 17 | 1,925 | 101 | 136 | 54 |
30 Sep 17 | 1,872 | 90 | 139 | 54 |
30 Jun 17 | 1,829 | 90 | 147 | 56 |
31 Mar 17 | 1,789 | 90 | 146 | 56 |
31 Dec 16 | 1,766 | 86 | 150 | 56 |
30 Sep 16 | 1,765 | 91 | 151 | 56 |
30 Jun 16 | 1,764 | 94 | 137 | 54 |
31 Mar 16 | 1,762 | 83 | 141 | 52 |
31 Dec 15 | 1,776 | 76 | 138 | 50 |
30 Sep 15 | 1,811 | 69 | 123 | 47 |
30 Jun 15 | 1,859 | 58 | 129 | 46 |
31 Mar 15 | 1,910 | 65 | 113 | 45 |
31 Dec 14 | 1,927 | 57 | 109 | 45 |
30 Sep 14 | 1,947 | 62 | 117 | 47 |
30 Jun 14 | 1,931 | 68 | 116 | 48 |
31 Mar 14 | 1,902 | 67 | 120 | 47 |
31 Dec 13 | 1,881 | 73 | 124 | 47 |
30 Sep 13 | 1,834 | 78 | 123 | 48 |
Des revenus de qualité: SCL has high quality earnings.
Augmentation de la marge bénéficiaire: SCL's current net profit margins (1.6%) are lower than last year (3.1%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: SCL's earnings have declined by 10.5% per year over the past 5 years.
Accélération de la croissance: SCL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: SCL had negative earnings growth (-56%) over the past year, making it difficult to compare to the Chemicals industry average (-4.8%).
Rendement des fonds propres
ROE élevé: SCL's Return on Equity (2.9%) is considered low.